US DMD Gene Therapy Marketing Director, Market Development

ROLE SUMMARY

The US Rare Endocrine and Neurology franchise is one of the most rapidly growing businesses across Pfizer Biopharma, with 60% 3-year CAGR, and a stellar pipeline including two breakthrough asset launches (“25 by 2025”) in the next 2 years. The team is progressing launch readiness efforts for Pfizer’s very first gene therapy medicine in a “Create” market, currently in late-stage (Phase 3) development for treatment of Duchenne Muscular Dystrophy (DMD). Fordadistrogene movaparvovec is truly a breakthrough medicine with potential to transform treatment of DMD, a rare and fatal neurological condition affecting young boys, currently with no effective treatment options.

US DMD Gene Therapy Marketing Director, Market Development will play a mission-critical role leading market development efforts for Pfizer’s first gene therapy launch in DMD. DMD is a nascent market with limited care infrastructure due to lack of effective treatment options. Complexity of the novel Gene therapy treatment pathway and high urgency to treat the DMD patient bolus necessitates the creation of a new treatment paradigm and rapid build-up/scale-up of care infrastructure. Primary responsibility of this role will be to develop and execute a comprehensive strategy for market development to establish a well-connected ecosystem of care including treatment and referring centers, and optimize treatment infrastructure for seamless patient management across the continuum of care. The Director will coordinate all efforts to lead development of care infrastructure in close collaboration with the US and Global DMD Gene therapy marketing and broader cross-functional teams.

This position requires senior level commercial expertise, exceptional strategic planning and cross-functional leadership skills, change agility and experience in developing innovative solutions launching into novel therapeutic areas. The successful candidate should demonstrate strong strategic, analytical, execution and decision-making skills, a problem-solving mindset and proven track record of fostering exemplary cross-functional collaboration and delivering exceptional results. This position will report to the US Rare Disease Neurology & Endocrine Franchise Lead.

ROLE RESPONSIBILITIES

Key role responsibilities include:

• Lead market development strategy for Pfizer’s first Gene Therapy (GTx) in DMD with a focus on first-time creation of end-to-end GTx treatment infrastructure

• Collaborate with cross-functional colleagues to identify, develop and orchestrate execution of key strategies and solutions to establish a novel ecosystem of care for DMD GTx patients

• Support development of referral networks ensuring connectivity across Gene Therapy infusion centers (GIC) and referring centers, and enabling patients to navigate through the GTx journey seamlessly

• Develop strategies and lead execution of tactics to ensure capacity to treat bolus of patients, enable GIC readiness, and provide broad, rapid, and seamless access to GTx

• Unlock opportunities for optimal treatment pathway with DMD Gene Therapy (GTx) across the care continuum including eligibility, GTx choice, access to treatment site, reimbursement, treatment initiation and follow-up

• Lead data and insights generation in tight collaboration with Medical, Business Analytics and Insights and HEOR teams to inform formation of the care model based on customer insights

• Collaborate with the SAS team with the goal of optimizing treatment infrastructure and GIC readiness in care network

• Define companion diagnostic strategy for GTx eligibility testing and ensure seamless integration into patient journey

• Implement innovative digital solutions in support of GIC readiness and care journey integration

• Develop novel platform to facilitate end-to-end GTx training with all key stakeholders at the treatment and referring centers

BASIC QUALIFICATIONS

• BA/BS degree required, MBA or other advanced degree highly desirable

• 10 years of pharmaceutical industry experience including marketing/healthcare consulting required

• Previous product launch and in-line US Marketing experience preferred

• Experience in Rare Disease/Specialty highly desirable

• Demonstrated success in developing, executing and measuring commercial plans and complex initiatives

• Track record of innovation and leadership

• Demonstrated leadership of cross functional matrix teams: Influences without formal authority, understands role/ position in the wider context; builds and maintains strong relationships of trust; able to influence without authority to set joint goals and share lessons learned; experience working in large organization across multiple functional partner lines

• Demonstrated ability to work effectively with varied internal stakeholders to identify key customer insights and translate into actionable strategies

• Solid business acumen and organizational skills with excellent interpersonal communication and negotiation skills for a wide variety of audiences, including senior management

• Strong analytical and strategic planning skills; detail and action oriented

• Self-motivated and a team player

• Demonstrated ability to manage and deliver results on multiple, complex, competing projects in a deadline-oriented environment

• Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact

NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS

Occasional domestic travel anticipated for RC or team meetings, agency presentations, training, POAs, congresses and KOL meetings.

Other Job Details

• Last Date to Apply for Job: October 4th

Relocation assistance may be available based on business needs and/or eligibility.

Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.